Potentiation of mitomycin C, 6-mercaptopurine, bleomycin, cis-diamminedichloroplatinum and 5-fluorouracil by mycotrienins and mycotrienols. 1983

M Kuwano, and K Ikezaki, and K Mamizuka, and S Komiyama, and H Seto, and N Otake, and M Sugita, and T Yamaguchi, and T Kishiye, and H Fukawa

Mycotrienins I and II and mycotrienols I and II are ansamycin antibiotics containing a triene structure, isolated from Streptomyces rishiriensis. An amphotericin B-resistant clone (AMBR-1) derived from cultured Chinese hamster V79 cells was cross-resistant to mycotrienins I and II, but not to mycotrienol I or II. These four ansamycin antibiotics were found to potentiate significantly the action of some anti-cancer agents including 5-fluorouracil, cis-diamminedichloroplatinum, bleomycin, mitomycin C and 6-mercaptopurine against cultured V79 cells. The action of adriamycin was not potentiated. These four ansamycin antibiotics showed a synergism spectrum similar to that of smaller polyene antibiotics.

UI MeSH Term Description Entries
D008937 Mitomycins A group of methylazirinopyrroloindolediones obtained from certain Streptomyces strains. They are very toxic antibiotics used as ANTINEOPLASTIC AGENTS in some solid tumors. PORFIROMYCIN and MITOMYCIN are the most useful members of the group.
D011809 Quinones Hydrocarbon rings which contain two ketone moieties in any position. They can be substituted in any position except at the ketone groups.
D001761 Bleomycin A complex of related glycopeptide antibiotics from Streptomyces verticillus consisting of bleomycin A2 and B2. It inhibits DNA metabolism and is used as an antineoplastic, especially for solid tumors. BLEO-cell,Blanoxan,Blenoxane,Bleolem,Bleomicina,Bleomycin A(2),Bleomycin A2,Bleomycin B(2),Bleomycin B2,Bleomycin Sulfate,Bleomycins,Bleomycinum Mack,Bléomycine Bellon,BLEO cell,BLEOcell,Bellon, Bléomycine,Mack, Bleomycinum,Sulfate, Bleomycin
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D003412 Cricetulus A genus of the family Muridae consisting of eleven species. C. migratorius, the grey or Armenian hamster, and C. griseus, the Chinese hamster, are the two species used in biomedical research. Hamsters, Armenian,Hamsters, Chinese,Hamsters, Grey,Armenian Hamster,Armenian Hamsters,Chinese Hamster,Chinese Hamsters,Grey Hamster,Grey Hamsters,Hamster, Armenian,Hamster, Chinese,Hamster, Grey
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D005472 Fluorouracil A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid. 5-FU,5-FU Lederle,5-FU Medac,5-Fluorouracil,5-Fluorouracil-Biosyn,5-HU Hexal,5FU,Adrucil,Carac,Efudex,Efudix,Fluoro-Uracile ICN,Fluoroplex,Fluorouracil Mononitrate,Fluorouracil Monopotassium Salt,Fluorouracil Monosodium Salt,Fluorouracil Potassium Salt,Fluorouracil-GRY,Fluorouracile Dakota,Fluorouracilo Ferrer Far,Fluoruracil,Fluracedyl,Flurodex,Haemato-FU,Neofluor,Onkofluor,Ribofluor,5 FU Lederle,5 FU Medac,5 Fluorouracil,5 Fluorouracil Biosyn,5 HU Hexal,Dakota, Fluorouracile,Fluoro Uracile ICN,Fluorouracil GRY,Haemato FU

Related Publications

M Kuwano, and K Ikezaki, and K Mamizuka, and S Komiyama, and H Seto, and N Otake, and M Sugita, and T Yamaguchi, and T Kishiye, and H Fukawa
October 1978, Cancer,
M Kuwano, and K Ikezaki, and K Mamizuka, and S Komiyama, and H Seto, and N Otake, and M Sugita, and T Yamaguchi, and T Kishiye, and H Fukawa
January 1980, Cancer treatment reports,
M Kuwano, and K Ikezaki, and K Mamizuka, and S Komiyama, and H Seto, and N Otake, and M Sugita, and T Yamaguchi, and T Kishiye, and H Fukawa
June 1984, British journal of cancer,
M Kuwano, and K Ikezaki, and K Mamizuka, and S Komiyama, and H Seto, and N Otake, and M Sugita, and T Yamaguchi, and T Kishiye, and H Fukawa
January 1988, Gan to kagaku ryoho. Cancer & chemotherapy,
M Kuwano, and K Ikezaki, and K Mamizuka, and S Komiyama, and H Seto, and N Otake, and M Sugita, and T Yamaguchi, and T Kishiye, and H Fukawa
October 1973, Antimicrobial agents and chemotherapy,
M Kuwano, and K Ikezaki, and K Mamizuka, and S Komiyama, and H Seto, and N Otake, and M Sugita, and T Yamaguchi, and T Kishiye, and H Fukawa
November 1983, Cancer research,
M Kuwano, and K Ikezaki, and K Mamizuka, and S Komiyama, and H Seto, and N Otake, and M Sugita, and T Yamaguchi, and T Kishiye, and H Fukawa
May 1990, Nihon Gan Chiryo Gakkai shi,
M Kuwano, and K Ikezaki, and K Mamizuka, and S Komiyama, and H Seto, and N Otake, and M Sugita, and T Yamaguchi, and T Kishiye, and H Fukawa
July 1982, Cancer,
M Kuwano, and K Ikezaki, and K Mamizuka, and S Komiyama, and H Seto, and N Otake, and M Sugita, and T Yamaguchi, and T Kishiye, and H Fukawa
January 1988, Cancer chemotherapy and pharmacology,
M Kuwano, and K Ikezaki, and K Mamizuka, and S Komiyama, and H Seto, and N Otake, and M Sugita, and T Yamaguchi, and T Kishiye, and H Fukawa
August 1986, Gan to kagaku ryoho. Cancer & chemotherapy,
Copied contents to your clipboard!